The influence of photodynamic therapy with 5-aminolevulinic acid on senescent skin cancer cells

Photodiagnosis and Photodynamic Therapy

Volumn 17, Issue , 2017, Pages 29-34

  Grigalavicius, Mantas ^a   Juraleviciute, Marina ^a   Kwitniewski, Mateusz ^b   Juzeniene, A ^a  

^a OSLO UNIVERSITY HOSPITAL   (Norway)

^b JAGIELLONIAN UNIVERSITY   (Poland)

Author keywords

5 Aminolevulinic acid; Photodynamic therapy; Senescence; Skin cancer

Indexed keywords

AMINOLEVULINIC ACID; BETA GALACTOSIDASE; BLEOMYCIN; PHOTOSENSITIZING AGENT;

ARTICLE; BLUE LIGHT; CELL AGING; CELL KILLING; CELL SURVIVAL; CELL VIABILITY; CONTROLLED STUDY; CYTOTOXICITY; HUMAN; HUMAN CELL; PHOTODYNAMIC THERAPY; PRIORITY JOURNAL; RADIATION EXPOSURE; SKIN CANCER CELL LINE; ULTRAVIOLET A RADIATION; AGING; APOPTOSIS; DRUG EFFECTS; PHOTOCHEMOTHERAPY; PROCEDURES; SKIN NEOPLASMS; TUMOR CELL LINE; ULTRAVIOLET RADIATION;

AGING; AMINOLEVULINIC ACID; APOPTOSIS; BLEOMYCIN; CELL LINE, TUMOR; CELL SURVIVAL; HUMANS; PHOTOCHEMOTHERAPY; PHOTOSENSITIZING AGENTS; SKIN NEOPLASMS; ULTRAVIOLET RAYS;

EID: 84999040107     PISSN: 15721000     EISSN: 18731597     Source Type: Journal    
DOI: 10.1016/j.pdpdt.2016.10.008     Document Type: Article

References (32)

1. [1] Leiter, U., Eigentler, T., Garbe, C., Epidemiology of skin cancer. Adv. Exp. Med. Biol. 810 (2014), 120–140.
2. [2] Demaria, M., Desprez, P.Y., Campisi, J., Velarde, M.C., Cell autonomous and non-autonomous effects of senescent cells in the skin. J. Invest. Dermatol. 135:7 (2015), 1722–1726.
3. [3] Kim, E., Rebecca, V., Fedorenko, I.V., Messina, J.L., Mathew, R., Maria-Engler, S.S., et al. Senescent fibroblasts in melanoma initiation and progression: an integrated theoretical, experimental, and clinical approach. Cancer Res. 73:23 (2013), 6874–6885.
4. [4] Lewis, D.A., Travers, J.B., Machado, C., Somani, A.K., Spandau, D.F., Reversing the aging stromal phenotype prevents carcinoma initiation. Aging (Albany, NY) 3:4 (2011), 407–416.
5. [5] Travers, J.B., Spandau, D.F., Lewis, D.A., Machado, C., Kingsley, M., Mousdicas, N., et al. Fibroblast senescence and squamous cell carcinoma: how wounding therapies could be protective. Dermatol. Surg. 39:7 (2013), 967–973.
6. [6] Amaro-Ortiz, A., Yan, B., D'Orazio, J.A., Ultraviolet radiation, aging and the skin: prevention of damage by topical cAMP manipulation. Molecules 19:5 (2014), 6202–6219.
7. [7] Zhang, L., Huang, X., Zhu, X., Ge, S., Gilson, E., Jia, R., et al. Differential senescence capacities in meibomian gland carcinoma and basal cell carcinoma. Int. J. Cancer 138:6 (2016), 1442–1452.
8. [8] Baker, D.J., Wijshake, T., Tchkonia, T., LeBrasseur, N.K., Childs, B.G., van de Sluis, B., et al. Clearance of p16Ink4a-positive senescent cells delays ageing-associated disorders. Nature 479:7372 (2011), 232–236.
9. [9] Zhou, B.R., Zhang, L.C., Permatasari, F., Liu, J., Xu, Y., Luo, D., ALA-PDT elicits oxidative damage and apoptosis in UVB-induced premature senescence of human skin fibroblasts. Photodiagn. Photodyn. Ther. 14 (2016), 47–56.
10. [10] Gordon, R.R., Nelson, P.S., Cellular senescence and cancer chemotherapy resistance. Drug Resist. Updates 15:1–2 (2012), 123–131.
11. [11] Shay, J.W., Roninson, I.B., Hallmarks of senescence in carcinogenesis and cancer therapy. Oncogene 23:16 (2004), 2919–2933.
12. [12] Lee, M., Lee, J.S., Exploiting tumor cell senescence in anticancer therapy. BMB Rep. 47:2 (2014), 51–59.
13. [13] Mosieniak, G., Strzeszewska, A., The role of cellular senescence in carcinogenesis and antitumor therapy. Postepy Biochem. 60:2 (2014), 194–206.
14. [14] Aoshiba, K., Tsuji, T., Nagai, A., Bleomycin induces cellular senescence in alveolar epithelial cells. Eur. Respir. J. 22:3 (2003), 436–443.
15. [15] Rodier, F., Campisi, J., Four faces of cellular senescence. J. Cell Biol. 192:4 (2011), 547–556.
16. [16] Ben-Porath, I., Weinberg, R.A., The signals and pathways activating cellular senescence. Int. J. Biochem. Cell Biol. 37:5 (2005), 961–976.
17. [17] Dimri, G.P., Lee, X., Basile, G., Acosta, M., Scott, G., Roskelley, C., et al. A biomarker that identifies senescent human cells in culture and in aging skin in vivo. Proc. Natl. Acad. Sci. U. S. A. 92:20 (1995), 9363–9367.
18. [18] Alster, O., Korwek, Z., Markers of cellular senescence. Postepy Biochem. 60:2 (2014), 138–146.
19. [19] Noodt, B.B., Berg, K., Stokke, T., Peng, Q., Nesland, J.M., Apoptosis and necrosis induced with light and 5-aminolaevulinic acid-derived protoporphyrin IX. Br. J. Cancer 74:1 (1996), 22–29.
20. [20] Agostinis, P., Berg, K., Cengel, K.A., Foster, T.H., Girotti, A.W., Gollnick, S.O., et al. Photodynamic therapy of cancer: an update. CA Cancer J. Clin. 61:4 (2011), 250–281.
21. [21] Piette, J., Volanti, C., Vantieghem, A., Matroule, J.Y., Habraken, Y., Agostinis, P., Cell death and growth arrest in response to photodynamic therapy with membrane-bound photosensitizers. Biochem. Pharmacol. 66:8 (2003), 1651–1659.
22. [22] Collaud, S., Juzeniene, A., Moan, J., Lange, N., On the selectivity of 5-aminolevulinic acid-induced protoporphyrin IX formation. Curr. Med. Chem. Anticancer Agents 4:3 (2004), 301–316.
23. [23] Kwitniewski, M., Jankowski, D., Jaskiewicz, K., Dziadziuszko, H., Juzeniene, A., Moan, J., et al. Photodynamic therapy with 5-aminolevulinic acid and diamino acid derivatives of protoporphyrin IX reduces papillomas in mice without eliminating transformation into squamous cell carcinoma of the skin. Int. J. Cancer 125:7 (2009), 1721–1727.
24. [24] Coppe, J.P., Desprez, P.Y., Krtolica, A., Campisi, J., The senescence-associated secretory phenotype: the dark side of tumor suppression. Annu. Rev. Pathol. 5 (2010), 99–118.
25. [25] Parrinello, S., Coppe, J.P., Krtolica, A., Campisi, J., Stromal-epithelial interactions in aging and cancer: senescent fibroblasts alter epithelial cell differentiation. J. Cell Sci. 118:Pt. 3 (2005), 485–496.
26. [26] Campisi, J., Cellular senescence: putting the paradoxes in perspective. Curr. Opin. Genet. Dev. 21:1 (2011), 107–112.
27. [27] Capparelli, C., Guido, C., Whitaker-Menezes, D., Bonuccelli, G., Balliet, R., Pestell, T.G., et al. Autophagy and senescence in cancer-associated fibroblasts metabolically supports tumor growth and metastasis via glycolysis and ketone production. Cell Cycle 11:12 (2012), 2285–2302.
28. [28] Achuthan, S., Santhoshkumar, T.R., Prabhakar, J., Nair, S.A., Pillai, M.R., Drug-induced senescence generates chemoresistant stemlike cells with low reactive oxygen species. J. Biol. Chem. 286:43 (2011), 37813–37829.
29. [29] Morton, C.A., Szeimies, R.M., Sidoroff, A., Braathen, L.R., European guidelines for topical photodynamic therapy part 2: emerging indications-field cancerization, photorejuvenation and inflammatory/infective dermatoses. J. Eur. Acad. Dermatol. Venereol. 27:6 (2013), 672–679.
30. [30] Ji, J., Zhang, L.L., Ding, H.L., Wang, H.W., Huang, Z., Wang, X.X., et al. Comparison of 5-aminolevulinic acid photodynamic therapy and red light for treatment of photoaging. Photodiagn. Photodyn. Ther. 11:2 (2014), 118–121.
31. [31] Collado, M., Gil, J., Efeyan, A., Guerra, C., Schuhmacher, A.J., Barradas, M., et al. Tumour biology: senescence in premalignant tumours. Nature, 436(7051), 2005, 642.
32. [32] Luo, X., Ruhland, M.K., Pazolli, E., Lind, A.C., Stewart, S.A., Osteopontin stimulates preneoplastic cellular proliferation through activation of the MAPK pathway. Mol. Cancer Res. 9:8 (2011), 1018–1029.